Medicine and Dentistry
Patient
82%
Paracetamol
78%
Acute Liver Failure
64%
Liver Injury
50%
Liver Transplantation
35%
Inpatient
29%
Intoxication
29%
Hepatitis E Virus
24%
Serum
22%
Hepatitis E
20%
Liver
19%
Prognosis
17%
Transplantation
16%
Serositis
16%
Infection
14%
Mortality
13%
Liver Toxicity
13%
Systemic Inflammatory Response Syndrome
12%
SOFA Score
11%
Combination Therapy
11%
Systematic Review
11%
Triage
11%
Organ
11%
Death
10%
Liver Cirrhosis
10%
Therapeutic Procedure
10%
Survival
9%
Acute on Chronic Liver Failure
9%
Morbidity
9%
Hepatocyte
8%
Chronic Hepatitis
8%
Acute Kidney Injury
8%
Macrophage
8%
Human
8%
Immunoglobulin M
7%
Programmed Cell Death
7%
Renal Replacement Therapy
7%
Virus Infection
7%
Monitoring
7%
High Mobility Group B1 Protein
7%
Laboratory
7%
Diagnostics
6%
Monocyte
6%
Diagnosis
6%
Liver Failure
6%
Pathogenesis
6%
Genotype
6%
Reperfusion Injury
6%
Syndrome
6%
Retrospective Cohort Study
6%
Pharmacology, Toxicology and Pharmaceutical Science
Paracetamol
100%
Acute Liver Failure
46%
Toxic Injury
45%
Liver Injury
33%
Hepatotoxicity
29%
Biological Marker
20%
Prognosis
17%
Inflammation
14%
Cohort Study
13%
Adverse Outcome
11%
Kidney Injury
11%
Phosphotransferase
11%
Death
8%
Chronic Hepatitis
7%
Stress Activated Protein Kinase
7%
Mortality
7%
microRNA 122
7%
Liver Failure
7%
Acute Kidney Failure
7%
Infection
6%
Pathogenesis
6%
microRNA
6%
Virus Infection
6%
Systemic Inflammatory Response Syndrome
6%
Organ Dysfunction Score
6%
Syndrome
6%
Toxic Hepatitis
6%
Replacement Therapy
6%
Cell Death
6%
Survival
5%
Animal
5%
Reperfusion Injury
5%
Ribavirin
5%
Acute on Chronic Liver Failure
5%
Knockout Mouse
5%
Interleukin 2 Receptor
5%
Sirtuin 1
5%
Cytokeratin 18
5%
End Stage Liver Disease
5%
High Mobility Group B1 Protein
5%
Circulating microRNA
5%
Liver Ischemia
5%
Neopterin
5%
Monocytopenia
5%
Hepatitis E Virus
5%
Toxicity
5%
Kidney Injury Molecule 1
5%
Troponin I
5%
Analgesic Agent
5%
Cell Adhesion Molecule
5%
Nursing and Health Professions
Tylenol
44%
Liver Injury
23%
Hepatitis E
22%
Patient
22%
Acute Liver Failure
21%
Intoxication
14%
Inpatient
10%
Acute on Chronic Liver Failure
9%
Virus Infection
9%
Survival
9%
Mortality
9%
Liver Transplantation
8%
Transplantation
6%
Ribavirin
6%
Prognosis
6%
Diagnosis
6%
Analysis
6%
Time
6%
Combination Therapy
6%
Cohort Analysis
6%
Sequential Organ Failure Assessment Score
6%
Marker
6%
Triage
6%
Organ Transplantation
6%
Death
5%
Liver Support
5%
Patient Referral
5%
Systemic Inflammatory Response Syndrome
5%
Morbidity
5%
Liver Toxicity
5%
Prediction
5%
Kidney Injury Molecule 1
5%
Neutrophil Lymphocyte Ratio
5%
Social Isolation
5%
Meta Analysis
5%
Epidemiology
5%
Troponin I
5%
Adverse Outcome
5%
